Zobrazeno 1 - 10
of 19
pro vyhledávání: '"F. Sánchez-Rubio"'
Autor:
B Serna Serrano, M Diaz Rangel, S Ruiz Sánchez, S Plata Paniagua, I Casas Hidalgo, F Sánchez Rubio, M Clemente Andújar, A Valladolid Walsh
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Ibrutinib is a potent Burton tyrosine kinase inhibitor involved in the proliferation and survival of chronic lymphatic leukaemia (CLL) B cells. This study was mainly motivated by suspensions for toxicity. Aim and objectives
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58f32f7e00c13f22ec1296c8778844f7
https://doi.org/10.1136/ejhpharm-2021-eahpconf.124
https://doi.org/10.1136/ejhpharm-2021-eahpconf.124
Nanotechnology in reproduction: Vitamin E nanoemulsions for reducing oxidative stress in sperm cells
Autor:
Maria del Mar Arroyo-Jimenez, María Rocío Fernández-Santos, F. Sánchez-Rubio, Alejandro Jurado-Campos, Virgilio Gómez-Rubio, Manuel J. Santander-Ortega, Julian Garde, M.V. Lozano, M. Plaza-Oliver, Ana J. Soler, J. Bartolomé-García, Pedro Javier Soria-Meneses
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Vitamin E is considered a powerful biological antioxidant; however, its characteristics such as high hydrophobicity and low stability limit its application. We propose to use nanotechnology as an innovative tool in spermatology, formulating nanoemuls
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a77ee2bf4bd0c6e91f52524189b8968
https://pubmed.ncbi.nlm.nih.gov/32768571
https://pubmed.ncbi.nlm.nih.gov/32768571
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
A Valladolid Walsh, J Marco del Rio, E Adrover Cebrian, F Sánchez Rubio, M Diaz Rangel, MV Lerma Gaude
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background The first-in-class oral inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6) palbociclib, combined with hormonal therapy, is a new standard of treatment in the first and second line for hormone receptor-positive (HR+), human epidermal gr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97925a71bd95976b8bb75ddd13d8cbcc
https://doi.org/10.1136/ejhpharm-2019-eahpconf.279
https://doi.org/10.1136/ejhpharm-2019-eahpconf.279
Autor:
G Romero Candel, EM García Martínez, F Sánchez Rubio, J Marco del Rio, I Pérez Alpuente, A Valladolid Walsh, S Ruiz Sánchez
Publikováno v:
Eur J Hosp Pharm
BACKGROUND: Linezolid is an antibiotic used for several infections, such as community acquired pneumonia, nosocomial pneumonia and skin and soft tissue infections. Its use has increased over the past years, raising concerns about the incidence in cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2caabcdba829092ee6fff8ecfa808b53
https://doi.org/10.1136/ejhpharm-2018-eahpconf.388
https://doi.org/10.1136/ejhpharm-2018-eahpconf.388
Autor:
Alejandro Maroto-Morales, Ana J. Soler, L. Castro-Vázquez, María Rocío Fernández-Santos, F. Sánchez-Rubio, Felipe Martínez-Pastor, Julian Garde, Olga García-Álvarez
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Cinnamtannin B-1 (CNB-1) is a naturally occurring trimeric A-type proanthocyanidin contained in several plants such as cinnamon (Cinnamomum zeylanicum). It is considered to be a potent antioxidant. The protective effect of CNB-1 against oxidative str
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3916f85e246670568f0497a7fb804c54
https://pubmed.ncbi.nlm.nih.gov/29776697
https://pubmed.ncbi.nlm.nih.gov/29776697
Autor:
JM Jimenez-Vizuete, J.Á. Monsalve-Naharro, E Domingo-Chiva, J Marco-del Río, Pardo-Ibañez, F Sánchez-Rubio, R Aldaz-Francés, J Cano-Molina, M Díaz-Rangel, Ana Valladolid-Walsh
Publikováno v:
General management.
Background Selective decontamination of the digestive tract has been proven to be the best measure to prevent ventilator associated pneumonia (VAP) and the only one that has demonstrated modest reductions in mortality. The preparations are typically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45c95e65722dcba6bfc19d5cc68ddb5b
https://doi.org/10.1136/ejhpharm-2017-000640.358
https://doi.org/10.1136/ejhpharm-2017-000640.358
Autor:
A Valladolid Wals, F Bautista Sirvent, F Sánchez Rubio, M Diaz Rangel, G Romero Candel, J Marco del Rio, I Pérez Alpuente, N Martinez Monteagudo, V Lopez Martinez, E Domingo Chiva
Publikováno v:
Clinical pharmacy.
Background Medication errors and their severity represent a failure in the medication use process and can increase morbidity and mortality in the emergency department. Purpose To describe the types of medication errors (ME) and severity in the observ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8fbda66edce3b58e26a78af397463da
https://doi.org/10.1136/ejhpharm-2017-000640.131
https://doi.org/10.1136/ejhpharm-2017-000640.131
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
PS-065 Ivabradine prescription according to pharmacovigilance risk assessment committee restrictions
Autor:
A Valladolid Walsh, N Monteagudo Martínez, M Diaz Rangel, J Marco del Rio, E Domingo Chiva, G Romero Candel, S Plata Paniagua, F Sánchez Rubio, EM García Martínez, L Victorio García
Publikováno v:
European Journal of Hospital Pharmacy. 23:A242.1-A242
Background The Pharmacovigilance Risk Assessment Committee (PRAC) published restrictions on the use of ivabradine in 2014 for patients diagnosed with chronic stable angina pectoris (CSAP): begin treatment only if resting heart rate (HR) is >70 bpm, i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6604097503f42da6e59c7edb76c6f8a4
https://doi.org/10.1136/ejhpharm-2016-000875.549
https://doi.org/10.1136/ejhpharm-2016-000875.549